People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Other Health Care, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cleveland HeartLab, Inc. | — | Other Health Care | Series B | $35.8M | $61.0M | 2011 |
| Convelo Therapeutics, Inc. | — | Pharma | Series A | $12.8M | $113.3M | 2017 |
Steven Landau at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven Landau on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tommy G. Thompson | 1 | 7 |
| Caleb Winder | 1 | 5 |
| Tommy Thompson | 1 | 5 |
| Keith Kerman | 1 | 4 |
| Bill Sanford | 1 | 2 |
| Gus Lawlor | 1 | 2 |
| Les Vinney | 1 | 2 |
| Drew Adams | 1 | 2 |
| Steve Gullans | 1 | 2 |
| Rebecca G. Holland | 1 | 1 |
| Steve Haynes | 1 | 1 |
| Tracy Smearman | 1 | 1 |
| Pamela G. Gornall | 1 | 1 |
| William G. Cadogan | 1 | 1 |
| Derrick Rossi | 1 | 1 |
| Ronald Richard | 1 | 1 |
| Paul Tesar | 1 | 1 |
| Wayne G. Wallace | 1 | 1 |
| Jacob Orville | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.